Rhovac ApS Company
RhoVac is an immuno-oncology company developing a novel therapeutic cancer vaccine that targets metastatic cancer cells.
Industry:
Peptides and Proteins
Estimated Revenue:
$1M to $10M
Investors Number:
1
Headquarters:
Hørsholm, Hovedstaden, Denmark
Employee Number:
11-50
Total Funding:
2770912
Founded Date:
2008-01-01
Last Funding Type:
Grant
Last Funding Date:
2019-08-22